Home » Gilead, LG Life Sciences in License Deal
Gilead, LG Life Sciences in License Deal
Gilead Sciences Inc. and LG Life Sciences Ltd. said Wednesday they entered a license agreement focused on caspase inhibitors for the treatment of fibrotic diseases.
Silicon Valley/San Jose Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May